|
AHA
Attacks Medication Safety Problem
The
American Hospital Association (AHA) has enlisted the aid of the
Institute for Safe Medication Practices (ISMP) of Huntington, PA,
to help hospitals examine and further improve medication safety
to reduce drug-related errors.
AHA
president Dick Davidson announced the new initiative during a December
7 White House briefing, the same day President Bill Clinton made
public his plans for a federal campaign to combat medical errors.
A recent report by the Institute of Medicine placed the issue of
medication errors in hospitals under close scrutiny by stating that
44,000 to 98,000 Americans die each year as a result of the errors.
As
part of the AHA effort, the ISMP will provide hospital leaders with
an inventory of successful practices for reducing errors. The practices
are based on the work of experts and organizations that study medication
safety and can be adopted in every hospital.
The
AHA and the ISMP developed a self-assessment tool, the "Medication
Safety Awareness Test," designed to help hospitals check and
track medication safety efforts and demonstrate progress on error
prevention. The two groups also plan to develop a non-punitive medication
error reporting process.
Also
on December 7, the AHA sent a Quality Advisory to all its member
hospitals urging executives and trustees to make safety a specific
priority. In the advisory, Davidson suggested that hospitals review
their policies and procedures for reporting and investigating errors,
placing an emphasis on the need to correct the problems that lead
to mistakes rather than passing blame for them.
The
Quality Advisory was re-issued to all hospitals in mid-February,
along with a confidential medical safety questionnaire.
Some
of the short-term fixes hospitals might implement, according to
the advisory, include: implementing a unit-dose system for all non-emergency
drugs, with necessary dose adjustments for children, older adults,
and patients with certain conditions; limiting the variety of devices
and equipment used in administering drugs, such as general purpose
infusion pumps; and creating special procedures and written protocols
for high-alert drugs.
In
the long term, hospitals should plan to increase the use of computers
in drug administration systems. Computers can be useful for generating
records, profiling in pharmacies, and implementing the use of bar
codes for administering medications.

Prescriptions
for Safety
Specific,
immediate steps can reduce drug errors-with support from senior
hospital managers and trustees. An American Hospital Association
(AHA) advisory issued to all hospital CEOs offers ideas for quick
fixes and longer-term solutions to hospitals' huge drug error problems.
After
reviewing information culled from 11 organizations working on patient
safety, the AHA suggested that hospitals could easily:
- Implement
unit dose systems for all non-emergency drugs and stress necessary
dose adjustment for children, older adults and patients with certain
conditions.
- Limit
the variety of devices and equipment used in administering drugs,
such as general purpose infusion pumps.
- Create
special procedures and written protocols for high-alert drugs.
For instance, hospitals can consider removing concentrated potassium
chloride/phosphate from floor stock and limit the number of possible
concentrations for dangerous drugs.
- Make
sure medical staff has new drug information by distributing newsletters
or having pharmacists make rounds with physicians and nurses.
Distribute drug error information from outside organizations.
- Consider
the error potential in all new products before approving their
use.
- Tell
patients how to use their medications safely at discharge and
encourage questions. In outpatient settings, inform patient what
they are taking, why and how to use it safely. Urge providers
to seek pharmacists' help with patients who are discharged on
more than five drugs.
- Make
pharmacists available. Hospitals that don't operate 24-hour pharmacies
should have pharmacists on call.
- Communicate
carefully. Avoid dangerous abbreviations. Make sure drug orders
include dose, strength, units, route, frequency, and rate; and
use only the metric system and drugs' full names.
- Standardize
processes, including doses, times of administration, packaging
and labeling, storage, dosing scales, and procedures for using
and storing high-alert drugs.
Substantial
changes require a long-term plan. The AHA recommends these costlier
steps:
- Develop
a voluntary system to monitor and report adverse drug events.
Reporting will increase if employees don't fear reprisal.
- Increase
use of computers in drug administration systems. Use computer-generated
or electronic drug administration records and computerize drug
profiling in pharmacies. Consider using bar coding for administering
drugs.
- Encourage
vendors to help place a system of checks into computerized pharmacy
systems-like screens for duplicate drug therapies, patient allergies,
and potential interactions and dose ranges.
- If
possible, have a 24-hour pharmacy; or use night formularies and
careful drug selection and storage procedures. Make pharmacist
consults available when they aren't onsite.

High-Alert
Medications And Patient Safety
Results
of a recent study conducted by the Institute for Safe Medication
Practices (ISMP) to determine the drugs and situations most likely
to cause harm to patients showed that a majority of medication errors
resulting in death or serious injury were caused by a specific list
of medications.
Drugs
having the highest risk of causing injury when misused are known
as high-alert medications. The top five high-alert medications identified
by the ISMP study are insulin; opiates and narcotics; injectable
potassium chloride (or phosphate) concentrate; intravenous anticoagulants
(heparin); and sodium chloride solutions above 0.9%.
According
to the ISMP, hospitals should develop and implement strategies for
patient safety related to the following common risk factors of these
high-alert medications. The Joint Commission on Accreditation of Healthcare
Organizations, in its 11th Sentinel Event Alert, agreed with
the ISMP study and offered additional suggestions for reducing risk.
Insulin
- Lack
of dose check systems
- Do
not store insulin and heparin vials near one another on a nursing
unit
- Spell
out the word "units" instead of using the abbreviation
"U" (which can be confused with "O," resulting
in a 10-fold overdose)
- Incorrect
rates being programmed into an infusion pump
Opiates
and Narcotics
- Parenteral
narcotics should not be stored in nursing areas as floor stock
- Alert
staff about confusion between hydromorphine and morphine
- Patient-controlled
analgesia (PCA) errors regarding concentration and rate
- Limit
the amount of opiates and narcotics in the floor stock
Injectable
Potassium Chloride or Phosphate Concentrate
- Do
not store concentrated potassium chloride/phosphate outside of
the pharmacy
- Use
commercially available premixed IV solutions
- Be
wary of requests for unusual concentrations
Intravenous
Anticoagulants (Heparin)
- Unclear
labeling regarding concentration and total volume
- Multi-dose
containers
- Confusion
between heparin and insulin due to similar measurement units and
proximity
Sodium
Chloride Solutions above 0.9%
- Remove
sodium chloride solutions (above 0.9%) from nursing units
- Standardize
and limit drug concentrations/formulations
- No
double check system in place

Physician
Handwriting Skills Need Improvement
A recent
Institute of Medicine report cites illegible handwriting as one
cause for medical errors. Due to widespread media and governmental
attention, experts predict that surveyors will check medical records
more thoroughly to make sure physicians write legibly.
According
to the February 2000 Briefings on JCAHO, legible handwriting
is not only a medical records and patient safety issue, it is also
a Joint Commission on Accreditation of Healthcare Organizations
(JCAHO) requirement. Standard I.M.3.2.1 in the Management of Information
chapter in the Comprehensive Accreditation Manual for Hospitals
(CAMH) states that the review of medical records addresses the
presence, timeliness, legibility, and authentication of the medical
record. Standard MS.8.2.3 in the Medical Staff chapter of the CAMH
states that the medical staff are expected to take a leadership
role in determining whether a patient's medical records are accurate,
timely, and legible.
Briefings
on JCAHO mentions the following suggestions for tackling the
problem of illegible handwriting:
- Catch
bad handwriting early. Have your medical records committee monitor
written progress notes, written orders and physician's signatures.
Several individuals should examine each chart; all should be able
to read it.
- Standard
hospital policy. Legible handwriting should be a criterion for
appointment for new physicians.
- Introduce
a computer entry system. By using a password, physicians can type
in an order at a computer terminal and send the order to a printer
in the area where they want the order sent. As long as they provide
the password, the JCAHO considers this to be a signature.
- Keep
an eye on quality. Monitoring the quality of documentation should
be a part of your ongoing record review, a process the JCAHO requires.
Hospitals
Not Prepared for Terrorists
The
threat of a large-scale terrorist attack involving chemical or biological
agents is significant, but hospitals and healthcare workers are
unprepared, according to an article in the January 12 issue of the
Journal of the American Medical Association.
Existing
hospital plans for responding to accidental exposures to hazardous
materials would be inadequate in the aftermath of a terrorist attack,
researchers said. They suggested hospitals better protect staff
and coordinate with outside emergency response teams. Researchers
also advised that hospitals publicize information about contaminant
risks in addition to caring for the injured.
In
the spring, the American Hospital Association plans through sponsorship
of the HHS' Office of Emergency Preparedness to conduct an invitational
forum to discuss hospital preparedness. The JAMA article is at http://jama.ama-assn.org/#2000.

ACHE
Category I Workshop
The
Arkansas Hospital Association and the Arkansas Healthcare Executives
Forum will cosponsor an ACHE workshop, "Advanced Negotiating,"
featuring Christopher Laubach, May 16-17, at the Holiday Inn Select
in Little Rock. The workshop is approved for 12 Category I (ACHE)
credits toward advancement and recertification in ACHE, and features:
- A
review of the basic negotiation process, including five key elements
for ensuring a successful agreement, and evaluation of negotiating
styles.
- Elements
necessary to an environment for successful negotiating, such as
trust, recognition of needs, alignment of objectives, and conflict
management.
- Advanced
negotiation techniques, including the presentation of persuasive
arguments, development of strong listening skills, creation of
value-added partnerships, and treatment of non-negotiators and
hard-ballers.
- Explanation
of negotiation dynamics in a capitated marketplace.
Registration
information about the workshop will be mailed in early March. Early
registration is recommended, because the meeting is limited to 40
participants.
Arkansas
Women Getting Breast Exams
According
to the Arkansas Department of Health, women in the state are doing
a better job at getting regular breast exams and mammograms. Among
women age 40 and over, 57.5% report they have received a mammogram
and clinical breast exam (CBE) within the last two years. That is
up from 53.9% in 1996, and is the highest rate recorded in the six
years the Health Department has tracked the exams.
Information
provided by the department's Center for Health Statistics also showed
the percentage of women 40 and older who have never had either a
mammogram or CBE fell to 25.5% in 1998, the lowest figure for that
rate. Data for the report was taken from the 1998 Arkansas Behavioral
Risk Factor Surveillance System.
In
1997, the Arkansas General Assembly passed legislation which provides
for screening, diagnosis, treatment, surveillance activities, and
public and professional education for women in Arkansas, all of
whom are at risk for developing breast cancer. The disease killed
383 people in Arkansas last year, including two men.
Flu
Pandemic Possible
In
cooperation with the U.S. Centers for Disease Control and Prevention
(CDC), the Arkansas Department of Health has begun preparations
for a potentially deadly, global flu outbreak expected to occur
within the next 50 years. The CDC has urged all states to develop
contingency plans for the possible outbreak, which could be similar
to flu pandemics which occurred in 1918, 1957, and 1968. The 1918
pandemic killed 20 million people worldwide.
According
to the CDC, the following information will explain the anticipated
course of an influenza pandemic:
- There
will be a five-month warning period of a coming pandemic. (Five
months will elapse from the time that a new strain of influenza
virus is identified until the influenza causes a worldwide pandemic.
During that time, a vaccine is likely to be developed and production
will begin.)
- Two
waves of the pandemic will affect each state. The second wave
will strike approximately six months after the first.
- The
first wave will have the following affects:
- Influenza
affects 25% of the population
- An
overall case-to-hospitalization rate of 4% will occur
- Fatalities
of those who contract the virus will be 1.7%
- The
second wave will have the following affects:
- Influenza
affects 5% of the population
- An
overall case-to-hospitalization rate of 4% will occur
- Fatalities
of those who contract the virus will be 1.7%
- Each
wave will last about one month and peak at two weeks.
- No
vaccine will be available until one month before the U.S. pandemic.
- The
vaccine supply will initially cover 20% of the population, and
will increase monthly. Therefore, there will not be enough vaccine
for the entire population.
According
to "The Economic Impact of Pandemic Influenza in the U.S.:
Priorities for Intervention," in the September-October 1999
Emerging Infectious Diseases Journal, the authors estimate
the next influenza pandemic in the U.S. will cause 89,000 to 207,000
deaths; 314,000-734,000 hospitalizations; 18-42 million outpatient
visits; and 20-47 million additional illnesses. The estimated economic
impact would be $71.3-$166.5 billion, excluding disruptions to commerce
and society.
For
more information about the influenza pandemic and its impact in
Arkansas, call Dr. Sandra Snow, medical epidemiologist, Arkansas
Department of Health, at 501-662-2169, or e-mail her at slsnow@mail.doh.state.ar.us.

Arkansas
Hometown Health Projects
Last
year, the Arkansas Department of Health implemented a pilot Hometown
Health Improvement Project (HHIP) in Boone County. The HHIP is a
community-driven project designed by the Health Department to help
local areas address their own unique healthcare needs.
The
project is geared to allow the department to help communities identify
where problems exist, develop and carry out plans that will allow
them to resolve those problems, bring together healthcare and community
leaders in partnerships that can provide needed resources and measure
progress to show solutions are paying off.
Ideally,
results will include reduced healthcare costs, a decrease in workplace
and school absences related to illness, and improvement in social
problems such as teen pregnancy and drinking, and child abuse.
Dr.
Fay Boozman, director of the Health Department, has announced the
Boone County pilot program has made such significant progress that
the project will be expanded into Polk, Scott, Montgomery, Union,
Pike, Baxter, Washington, Crittenden, and Fulton counties.

Central
Arkansas VA
Participates In Clinical Trial
Cardiology
researchers at the Central Arkansas Veterans Healthcare System (CAVHS)
announced that they are participating in a national clinical trial
to evaluate a new non-invasive treatment for patients with claudication
(leg muscle pain brought on by walking and relieved by rest) due
to peripheral artery disease (PAD). The compound, called fibroblast
growth factor (FAF-2) is a recombinant form of a naturally occurring
protein that has been shown to sitmulate cell and blood vessel growth
in preclinical studies.
The
Phase II clinical trial is intended to evaluate the efficacy and
safety of FGF-2 in patients with moderate to severe claudication
due to PAD. Patients enrolled in the study are followed for six
months to measure changes in their exercise capacity and quality
of life. In addition, changes in peripheral blood flow are measured
at some centers. The study is being conducted by a newly formed
group of physicians, the Peripheral Atherosclerosis Research Consortium
(PARC). There are 22 medical facilities in the U.S. currently participating
in the Phase II clinical trial. Reasons cited for the selection
of CAVHS as a participant include the excellence of research done
in other studies, as well as the quality and volume of clinical
practice by the institution's physicians.
The
Central Arkansas Veterans Healthcare System, a flagship Department
of Veterans Affairs healthcare provider, is one of the largest and
busiest VA medical centers in the country. Its two hospitals, located
in Little Rock and North Little Rock, anchor a broad spectrum of
inpatient and outpatient healthcare services, ranging from disease
prevention through primary care, to complex surgical procedures,
to extended rehabilitative care.
|